文献速递物质与行为成瘾

阿片使用障碍的药物治疗

Medication Treatment of Opioid Use Disorder.
PubMed 文献 · Biol Psychiatry · 2019-07-02

阿片使用障碍(OUD)是一种慢性复发性疾病,常伴随法律、人际和就业问题。美沙酮(全激动剂)、丁丙诺啡(部分激动剂)和纳曲酮(拮抗剂)是有效的药物;口服美沙酮证据最强,治疗时间越长预后越好。新长效制剂和带回家纳洛酮可改善依从性与安全性,但获取障碍和污名化限制所有药物治疗。

要点

  • 美沙酮、丁丙诺啡和纳曲酮是OUD有效药物,口服美沙酮证据最强。
  • 治疗时间越长越有利于恢复社会联系和改善结局。
  • 新长效丁丙诺啡/纳曲酮制剂及带回家纳洛酮可应对依从性与过量风险。

核心结论

  • 美沙酮、丁丙诺啡和纳曲酮对OUD有效,口服美沙酮证据最强,延长治疗可改善结局。
  • 新长效制剂和带回家纳洛酮有助于解决依从性与过量风险,但获取障碍和污名化限制所有药物治疗。

研究设计与样本

  • 本文为综述,未报告系统检索范围、样本量或研究设计细节。

主要发现

  • 美沙酮和丁丙诺啡通过抑制阿片戒断症状和减弱其他阿片效应起效,纳曲酮阻断阿片激动剂效应。
  • 口服美沙酮证据最强,较长治疗时间与社会联系恢复和更好结局相关。
  • 离开治疗后复发和过量风险高,美沙酮和丁丙诺啡治疗还有转移和误用风险。
  • 新长效丁丙诺啡和纳曲酮制剂已开发以应对安全性和依从性问题。
  • 对上述治疗无应答者,监督下注射阿片治疗(处方海洛因)证据积累;带回家纳洛酮可逆转过量。

关键数值与推荐

  • 有效药物包括美沙酮(全阿片激动剂)、丁丙诺啡(部分激动剂)和纳曲酮(阿片拮抗剂)。
  • 口服美沙酮证据最强;延长治疗时间与更好结局相关。
  • 带回家纳洛酮用于逆转阿片过量,旨在预防致命过量。

临床怎么用

  • 优先选用证据最强的口服美沙酮,并延长治疗时间以改善结局。
  • 可考虑新长效丁丙诺啡或纳曲酮制剂以提高依从性和安全性。
  • 对无应答者评估监督下注射阿片治疗,并为患者提供带回家纳洛酮。
  • 需解决获取障碍和污名化以扩大有效治疗的可及性。

局限性

  • 治疗可能因依从性差、复发和离开治疗后过量风险增加而受限。
  • 美沙酮和丁丙诺啡有转移和误用风险;所有药物治疗受获取不足和污名化限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Opioid use disorder (OUD) is a chronic, relapsing condition, often associated with legal, interpersonal, and employment problems. Medications demonstrated to be effective for OUD are methadone (a full opioid agonist), buprenorphine (a partial agonist), and naltrexone (an opioid antagonist). Methadone and buprenorphine act by suppressing opioid withdrawal symptoms and attenuating the effects of other opioids. Naltrexone blocks the effects of opioid agonists. Oral methadone has the strongest evidence for effectiveness. Longer duration of treatment allows restoration of social connections and is associated with better outcomes. Treatments for OUD may be limited by poor adherence to treatment recommendations and by high rates of relapse and increased risk of overdose after leaving treatment. Treatment with methadone and buprenorphine has the additional risk of diversion and misuse of medication. New depot and implant formulations of buprenorphine and naltrexone have been developed to address issues of safety and problems of poor treatment adherence. For people with OUD who do not respond to these treatments, there is accumulating evidence for supervised injectable opioid treatment (prescribing pharmaceutical heroin). Another medication mode of minimizing risk of overdose is take-home naloxone. Naloxone is an opioid antagonist used to reverse opioid overdose, and take-home naloxone programs aim to prevent fatal overdose. All medication-assisted treatment is limited by lack of access and by stigma. In seeking to stem the rising toll from OUD, expanding access to approved treatment such as methadone, for which there remains the best evidence of efficacy, may be the most useful approach.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Bell J, Strang J. Medication Treatment of Opioid Use Disorder. Biol Psychiatry. 2019. PMID: 31420089. doi:10.1016/j.biopsych.2019.06.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。